{"disease":{"id":"luminal-b","name":"luminal b"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07492433","title":"Risk Factors, Incidence, and Clinical Impact of Intraluminal Thrombosis Following FET and TEVAR","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":800,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT05972070","title":"Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"ROM Technologies, INC","has_results":false},{"nct_id":"NCT06525675","title":"Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)","phase":"","overall_status":"COMPLETED","enrollment_count":419,"lead_sponsor_name":"MedSIR","has_results":false},{"nct_id":"NCT02806258","title":"Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":362,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT05620134","title":"Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":263,"lead_sponsor_name":"Salubris Biotherapeutics Inc","has_results":false},{"nct_id":"NCT05982496","title":"18F FES-PET/MRI for Tailoring Treatment of Luminal a and Lobular Breast Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":221,"lead_sponsor_name":"Università Vita-Salute San Raffaele","has_results":false},{"nct_id":"NCT03875573","title":"Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":147,"lead_sponsor_name":"Jules Bordet Institute","has_results":false},{"nct_id":"NCT04118062","title":"Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)","phase":"NA","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"Institut Curie","has_results":false},{"nct_id":"NCT05163106","title":"Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"University Hospital, Akershus","has_results":false},{"nct_id":"NCT03356860","title":"Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer.","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Grand Hôpital de Charleroi","has_results":false},{"nct_id":"NCT05640778","title":"Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER)","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT03715959","title":"Nipple Aspirate Fluid in Detecting Breast Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT06585969","title":"A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Danish Breast Cancer Cooperative Group","has_results":false}],"total":13},"guidelines":[],"source":"Drug Landscape verified database"}